Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...
Ahmedabad-based Khyati Multispecialty Hospital made headlines after 2 patients registered under scheme died following ...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture Apalutamide Tablets, 60 mg.
Zydus Lifesciences Ltd has received USFDA approval to manufacture a generic version of Apalutamide tablets for prostate cancer treatment. The 60 mg tablets will be produced in Ahmedabad, addressing a ...